Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?

Relapses of Plasmodium vivax malaria threaten disease elimination: time to deploy tafenoquine in India?

Bibliographic Details
Main Authors:	Amit Sharma, Manju Rahi, Sundus Shafat Ahmad
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2021-02-01
Series:	BMJ Global Health
Online Access:	https://gh.bmj.com/content/6/2/e004558.full

Similar Items

Tafenoquine for the prevention of Plasmodium vivax malaria relapse
by: James A Watson, et al.
Published: (2021-05-01)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016-07-01)

Neurological and psychiatric safety of tafenoquine in Plasmodium vivax relapse prevention: a review
by: Stephan Duparc, et al.
Published: (2020-03-01)

Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
by: Narimane Nekkab, et al.
Published: (2021-04-01)

Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
by: Hounkpatin AB, et al.
Published: (2019-03-01)

Safety and Efficacy of Tafenoquine for Plasmodium vivax Malaria Prophylaxis and Radical Cure: Overview and Perspectives
by: Markus MB
Published: (2021-09-01)

Coverage enhancement and community empowerment via commercial availability of the long-lasting nets for malaria in India
by: Manju Rahi, et al.
Published: (2021-11-01)

For malaria elimination India needs a platform for data integration
by: Amit Sharma, et al.
Published: (2020-12-01)

Tafenoquine: A 2018 Novel FDA-Approved Prodrug for the Radical Cure of <i>Plasmodium vivax</i> Malaria and Prophylaxis of Malaria
by: Annie Mayence, et al.
Published: (2019-07-01)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
by: James Watson, et al.
Published: (2018-04-01)

Mefloquine as a prophylaxis for malaria needs to be revisited
by: Sundus Shafat Ahmad, et al.
Published: (2021-12-01)

Determinants of relapse periodicity in <it>Plasmodium vivax </it>malaria
by: White Nicholas J
Published: (2011-10-01)

Plasmodium falciparum and Plasmodium vivax epidemiology in an era of malaria elimination
by: E. Collins, et al.
Published: (2020-12-01)

Malaria elimination in India—The way forward
by: Susanta K Ghosh, et al.
Published: (2019-01-01)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
by: Pavani Reddy, et al.
Published: (2006-11-01)

The potential elimination of Plasmodium vivax malaria by relapse treatment: insights from a transmission model and surveillance data from NW India.
by: Manojit Roy, et al.
Published: (2013-01-01)

COVID-19 and Plasmodium vivax malaria co-infection
by: Sundus Sardar, et al.
Published: (2020-01-01)

Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure.
by: Kamala Thriemer, et al.
Published: (2021-04-01)

A randomized, double-blind, active-control trial to evaluate the efficacy and safety of a three day course of tafenoquine monotherapy for the treatment of Plasmodium vivax malaria.
by: Mark M Fukuda, et al.
Published: (2017-01-01)

Reactive Case Detection for Plasmodium vivax Malaria Elimination in Rural Amazonia.
by: Pablo S Fontoura, et al.
Published: (2016-12-01)

Understanding the population genetics of <it>Plasmodium vivax </it>is essential for malaria control and elimination
by: Arnott Alicia, et al.
Published: (2012-01-01)

India can consider integration of three eliminable disease control programmes on malaria, lymphatic filariasis, and visceral leishmaniasis.
by: Manju Rahi, et al.
Published: (2021-05-01)

Plasmodium vivax Malaria
by: Dhanpat K. Kochar, et al.
Published: (2005-01-01)

Malaric relapses due to Plasmodium Vivax Reinfección engógena por Plasmodium vivax
by: Cecilia Giraldo, et al.
Published: (1991-01-01)

Plasmodium vivax malaria elimination: should innovative ideas from the past be revisited?
by: Fernando Fonseca Val, et al.
Published: (2014-08-01)

Plasmodium vivax and Plasmodium falciparum at the crossroads of exchange among islands in Vanuatu: implications for malaria elimination strategies.
by: Chim W Chan, et al.
Published: (2015-01-01)

The epidemiology of Plasmodium vivax and Plasmodium falciparum malaria in China, 2004-2012: from intensified control to elimination
by: Zhang, Qian, et al.
Published: (2014)

Relapse of imported <it>Plasmodium vivax</it> malaria is related to primaquine dose: a retrospective study
by: Townell Nicola, et al.
Published: (2012-06-01)

The anaemia of <it>Plasmodium vivax</it> malaria
by: Douglas Nicholas M, et al.
Published: (2012-04-01)

Population genomics of Plasmodium vivax in Panama to assess the risk of case importation on malaria elimination.
by: Lucas E Buyon, et al.
Published: (2020-12-01)

Rising report of Plasmodium vivax in sub-Saharan Africa: Implications for malaria elimination agenda
by: Mary Aigbiremo Oboh, et al.
Published: (2020-11-01)

<i>Plasmodium vivax</i> Genetic Diversity in Panama: Challenges for Malaria Elimination in Mesoamerica
by: Ana María Santamaría, et al.
Published: (2021-08-01)

The clinicopathologic manifestations of plasmodium vivax malaria in children
by: Hareesh Resu, et al.
Published: (2019-01-01)

Clinical and epidemiological characterization of severe Plasmodium vivax malaria in Gujarat, India
by: Anupkumar R. Anvikar, et al.
Published: (2020-01-01)

The prevention and treatment of Plasmodium vivax malaria.
by: Cindy S Chu, et al.
Published: (2021-04-01)

Neutrophil paralysis in Plasmodium vivax malaria.
by: Fabiana Maria de Souza Leoratti, et al.
Published: (2012-01-01)

Concurrent Plasmodium vivax Malaria and Dengue
by: Stan Deresinski
Published: (2006-11-01)

Changing profile of Plasmodium vivax malaria
by: M.E. Yeolekar, et al.
Published: (2014-04-01)

Plasmodium vivax malaria: Is it actually benign?
by: Harpal Singh, et al.
Published: (2011-06-01)

The role of cytokines in Plasmodium vivax malaria
by: K. N. Mendis, et al.
Published: (1992-01-01)